Evaluation of effects of unmodified niacin on fasting and postprandial plasma lipids in normolipidemic men with hypoalphalipoproteinemia

This publication has 47 references indexed in Scilit:

• Triglyceride, High-Density Lipoprotein, and Coronary Heart Disease
  JAMA, 1993
• Distribution of Lipid Phenotypes in Community-Living Men With Coronary Heart Disease
  Archives of internal medicine (1960), 1992
• Long-term predictors of subsequent cardiovascular events with coronary artery disease and 'desirable' levels of plasma total cholesterol.
  Circulation, 1992
• Marked benefit with sustained-release niacin therapy in patients with “isolated” very low levels of high-density lipoprotein cholesterol and coronary artery disease
  The American Journal of Cardiology, 1992
• Lipoprotein cholesterol, apolipoprotein A-I and B and lipoprotein (a) abnormalities in men with premature coronary artery disease
  Journal of the American College of Cardiology, 1992
• Hepatic toxicity of unmodified and time-release preparations of niacin
  The American Journal of Medicine, 1992
• A Prospective Study of Cholesterol, Apolipoproteins, and the Risk of Myocardial Infarction
  New England Journal of Medicine, 1991
• Niacin Revisited
  Archives of internal medicine (1960), 1991
• High density lipoprotein cholesterol, total cholesterol screening, and myocardial infarction. The Framingham Study.
  Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1988
• Contrasting effects of unmodified and time-release forms of niacin on lipoproteins in hyperlipidemic subjects: Clues to mechanism of action of niacin
  Metabolism, 1985